Carrier-free siRNA medicine for osteoarthritis
Carrier Free siRNA Conjugates as Disease Modifying Osteoarthritis Drugs
A new carrier-free genetic medicine aims to slow or stop osteoarthritis in people with joint degeneration.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11190958 on NIH RePORTER |
What this research studies
This research is developing tiny genetic medicines called siRNAs that are chemically modified so they don't need a carrier and could be injected into your joints. Scientists will test and improve these carrier-free conjugates in lab experiments and animal models to make sure they are stable, reach joint tissues, and are safe. The idea is to turn off the genes that drive cartilage damage and inflammation so the disease itself is slowed rather than just masking pain. If these preclinical steps succeed, the approach could advance to human trials where people with osteoarthritis could be invited to participate.
Who could benefit from this research
Good fit: Ideal candidates would be people with symptomatic, progressive osteoarthritis (for example of the knee) once human trials begin.
Not a fit: People without osteoarthritis, those with joint pain from other causes, or people already scheduled for joint replacement may not benefit from this approach.
Why it matters
Potential benefit: Could slow or stop cartilage loss in osteoarthritis, reduce pain, and improve mobility.
How similar studies have performed: Carrier-free siRNA drugs have been approved for liver diseases, showing the approach can work clinically, but applying carrier-free siRNA to osteoarthritis is new and unproven in humans.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Duvall, Craig Lewis — Vanderbilt University
- Study coordinator: Duvall, Craig Lewis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.